(PharmaNewsWire.Com, April 20, 2021 ) The increasing R&D investments in the pharmaceutical and biotechnology industry as well as increasing importance of chromatography tests for drug approvals, are high growth prospects for the chiral chromatography column market during the forecast period.
A few major players that have an extensive geographic presence dominate the chiral chromatography column industry globally. The leading players in the chiral chromatography column market include Agilent Technologies (US), Thermo Fisher Scientific (US), Waters Corporation (US), Daicel Corporation (Japan), Bio-Rad Laboratories (US), W.R.Grace & Co. (US), Merk Group (Germany), GL Sciencies (Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva (US), ES Industruies (US), and Phenomenex (US).
The major strategies adopted by these players include new product launches, contracts & agreements, mergers, and investments & expansions. New product launches was the most commonly adopted strategies from July 2018 to June 2020.
Agilent Technologies is the global leader in the life sciences, diagnostics, and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, and expertise. The company operates through three business segments, namely, Life Sciences and Applied Markets, Agilent CrossLab, and Diagnostics and Genomics. Under the Life Sciences and Applied Markets segment, the company offers liquid chromatography (LC) systems and components, liquid chromatography-mass spectrometry (LCMS) systems, gas chromatography (GC) systems and components, and gas chromatography-mass spectrometry (GCMS) systems.
It also offers inductively coupled plasma mass spectrometry (ICP-MS) instruments, atomic absorption (AA) instruments, microwave plasma-atomic emission spectrometry (MP-AES) instruments, and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments. The company has its presence in more than 110 countries and sales offices, logistics centers, and business facilities in Europe, the Americas, and the Asia Pacific. Its principal competitors in the life sciences and applied markets arena include Danaher Corporation, PerkinElmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation.
Thermo Fisher Scientific offers various products and services such as analytical reagents, antibody applications, chromatography, clinical microbiology, clinical and translational research, diagnostic testing, and laboratory equipment. It caters its techniques to various end-user industries such as pharmaceutical, biotechnology, academic, government, environmental and industrial research, and clinical laboratory. The company operates its business through four segments, namely, Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Under the Analytical Instruments segment, the company offers chromatography instruments. Its chromatography product line includes high-performance liquid chromatography, ion chromatography, and gas chromatography systems, all of which are supported by its Chromeleon chromatography data system software. The company operates worldwide and serves more than 400,000 customers. The company provides pharmaceutical services through its industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
